Sign in

MinhTri Nguyen, MD

@minhtrimd.bsky.social
447 followers 731 following 23 posts

Medical Oncologist at Stanford | Certified Coach | Researcher in emotional intelligence | Always learning, and finding good food. My opinions are my own. #Medsky #Oncosky

PostsRepliesMedia
MinhTri Nguyen, MD @minhtrimd.bsky.social · 24/04/2025
Sometimes Oncology just doesn’t follow guidelines. I use Primum when I hit those moments. Thoughtful, fast answers from peers who know their stuff. If you're curious: Great for fellows and those already in practice.
app.primum.co
Primum
A digital platform helping patients receive better care closer to home. We connect oncologists with sub-specialists to discuss their most complex cancer cases.
030
Reposted by MinhTri Nguyen, MD
The ASCO Post @ascopost.bsky.social · 07/04/2025
Is surgery always necessary for invasive breast cancer? 🩺🔍 New research is challenging the status quo and exploring less invasive paths for treatment. A must-read for oncology professionals. Read more: ascopost.com/news/april-2... #BreastCancer #CancerResearch #ASCO2025
001
MinhTri Nguyen, MD @minhtrimd.bsky.social · 30/01/2025
No generational judgement—disheartening to see burnout at all. Especially in In a field that clearly still holds joy for those that practice. The landscape is not what it used to be & we’ve trained to be nimble with medical decision—not staffing, prior auth, or EMR burden.
020
Reposted by MinhTri Nguyen, MD
The ASCO Post @ascopost.bsky.social · 28/01/2025
The FDA has approved trastuzumab deruxtecan (T-DXd) for patients with HR-positive, HER2-low, or HER2-ultralow metastatic breast cancer based on DESTINY-Breast06 trial results. #BreastCancer #Oncology ascopost.com/news/january...
052
Reposted by MinhTri Nguyen, MD
Jame Abraham, MD, FACP @jameabraham.bsky.social · 17/01/2025
Thank you for sharing your incredible immigrant story from Vietnam - to selling strawberries on the streets of Maine - one of our best fellows at @clevelandclinic.bsky.social and now as an oncologist in @Stanford medicine www.linkedin.com/posts/minhtr... @minhtrimd.bsky.social inspiring!
linkedin.com
MinhTri Nguyen, MD on LinkedIn: From strawberries to stethoscopes: lessons in humanity from a future…
Thank you to Kevin Pho, M.D. for publishing my story. And Kim Downey for encouraging me to submit my personal statement “as is”. As I continue to practice in…
131
MinhTri Nguyen, MD @minhtrimd.bsky.social · 29/12/2024
I was born in the mountains of 🇻🇳. At 5 my parents sought the land of opportunity 🇺🇸. This Dec our family reunited in 🇻🇳. My country has changed and so have we. Change = opportunity. From my Fam to yours: Happy new years! With the change, I hope you also find your opportunities to grow.
050
MinhTri Nguyen, MD @minhtrimd.bsky.social · 22/12/2024
A bit late on the announcement but thrilled to be selected for the Stanford Physician Leadership Certificate Program! I look forward to learning and enhancing my leadership skills and leadership theory. I accept! (-ed before the deadline) :) #leadership
120
Reposted by MinhTri Nguyen, MD
NEJM.org @nejm.org · 11/12/2024
The selective estrogen-receptor degrader imlunestrant plus abemaciclib led to a median progression-free survival of 9.4 months among patients with ER-positive, HER2-negative breast cancer (vs. 5.5 months with imlunestrant alone). Full EMBER-3 trial results: nej.md/4fZ74HX #MedSky #SABCS24
Kaplan–Meier estimates of progression-free survival among all 426 patients in the imlunestrant–abemaciclib and imlunestrant groups who had undergone randomization concurrently.
0307
MinhTri Nguyen, MD @minhtrimd.bsky.social · 12/12/2024
I’ve found many apps to be extremely useful as a fellow and practicing oncologist. For a quick (usually less than 48 hrs) curbside consult to an Oncologist, Hematologist, RadOnc, Pharmacist etc. I’ve been using Primum. You can also ask anonymously. See link. #oncsky #cansky #medsky
app.primum.co
Primum
A digital platform helping patients receive better care closer to home. We connect oncologists with sub-specialists to discuss their most complex cancer cases.
120
Reposted by MinhTri Nguyen, MD
Nathan Pennell MD, PhD, FASCO @n8pennell.bsky.social · 08/12/2024
We have known for decade+ that you can detect progression using ctDNA months before you see it on scans. But until we show that it impacts outcomes to change tx earlier all it does is make ppl anxious and abandon treatments (TKIs) that may still be helping. Most MRD use today is marketing over data.
43614
MinhTri Nguyen, MD @minhtrimd.bsky.social · 02/12/2024
Wrote this haiku before #ASHaiku for #ASH24 but I’d like to shamelessly repost for submission. In response to @oligoclonalband.bsky.social ‘s cooly made Neuro-skirt.
260
Reposted by MinhTri Nguyen, MD
The OncoAlert Network 🚨 @oncoalert.bsky.social · 28/11/2024
Day 2 of #BLADDR24 Dr Rob Jones Case metastatic UCa Treatment sequencing in the era of combination therapies Emphasizes that first-line therapy with EV and P is poised to become the new SoC @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social
084
MinhTri Nguyen, MD @minhtrimd.bsky.social · 23/11/2024
My interview on developing leaders in healthcare with James Stoller, MD and Scott Allen, Ph.D. #leadership #medsky
buzzsprout.com
James Stoller, MD & MinhTri Nguyen, MD - Developing Leaders in Healthcare - Phronesis: Practical Wisdom for Leaders with Scott Allen
Dr. Stoller is Chairman of the Education Institute at Cleveland Clinic. He holds the Jean Wall Bennett Professorship of Medicine at Cleveland Clinic Lerner College of Medicine and the Samson Global Le...
060
MinhTri Nguyen, MD @minhtrimd.bsky.social · 23/11/2024
@valdesan.bsky.social to the rescue! Oncology Vol 1 and 2 starter packs (links included in the packs) go.bsky.app/UP8aWPd #medsky #oncsky #oncosky #oncology
053
Reposted by MinhTri Nguyen, MD
Paolo Tarantino, MD @ptarantinomd.bsky.social · 23/11/2024
Interesting case series (n=3) from Emory of patients with pretreated HER2+ and HER2-low MBC with severe hepatic impairment tolerating well and deriving clinical benefit from dose-reduced T-DXd. www.sciencedirect.com/science/arti...
sciencedirect.com
Administration of Trastuzumab Deruxtecan in Metastatic Breast Cancer Patients with Severe Hepatic Impairment
Trastuzumab deruxtecan (T-DXd) shows efficacy in HER2-positive and HER2-low metastatic breast cancer (MBC), but its safety in patients with hepatic im…
061
MinhTri Nguyen, MD @minhtrimd.bsky.social · 19/11/2024
Amazing. Imagine the next level: Incorporating such large language models into our EMR systems to provide suggested matched clinical trials in real time! These LLM are already being trialed and implemented for inbox management at some institutions. Anxiously hopeful. 🙏
010
MinhTri Nguyen, MD @minhtrimd.bsky.social · 18/11/2024
Can we get one of those nifty “click to follow all of these profiles” for #oncosky #cansky? I’m thinking someone must being working on this…right? Or did I just volunteer myself? 😭 👉👃 #medsky
4182
MinhTri Nguyen, MD @minhtrimd.bsky.social · 17/11/2024
It’s getting a little hairy over there 👀…Time to find bluer skies. 🦋 #medsky #oncosky
1110
Reposted by MinhTri Nguyen, MD
Nathan Pennell MD, PhD, FASCO @n8pennell.bsky.social · 12/11/2024
Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
brnw.ch
ASCO Election
ASCO Election
0182